Wall Street Zen upgraded shares of Azenta (NASDAQ:AZTA – Free Report) from a hold rating to a buy rating in a research note published on Saturday,Wall Street Zen reports.
Several other research analysts have also recently weighed in on AZTA. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. Needham & Company LLC increased their price objective on Azenta from $37.00 to $57.00 and gave the stock a “buy” rating in a report on Wednesday, November 11th. Finally, Jefferies Financial Group lifted their target price on Azenta from $44.00 to $52.00 and gave the company a “buy” rating in a research report on Wednesday, November 11th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $47.60.
Read Our Latest Research Report on AZTA
Azenta Trading Up 3.4%
Shares of NASDAQ AZTA opened at $47.22 on Friday. The firm has a market cap of $2.07 billion, a PE ratio of -13.04 and a beta of 1.47. Azenta has a 1-year low of $15.93 and a 1-year high of $50.06. The company has a fifty day moving average price of $36.83 and a 200 day moving average price of $28.60.
Azenta (NASDAQ:AZTA – Get Free Report) last released its earnings results on Tuesday, November 10th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.17. Azenta had a positive return on equity of 1.41% and a negative net margin of 26.86%. The firm had revenue of $167.09 million during the quarter, compared to analysts’ expectations of $160.16 million. Equities research analysts forecast that Azenta will post 0.69 EPS for the current year.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in Azenta in the second quarter valued at $192,152,000. GW&K Investment Management LLC lifted its position in Azenta by 0.4% during the 3rd quarter. GW&K Investment Management LLC now owns 992,616 shares of the company’s stock worth $34,633,000 after buying an additional 4,187 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in Azenta by 16.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,613,914 shares of the company’s stock worth $34,183,000 after buying an additional 225,867 shares in the last quarter. Front Street Capital Management Inc. bought a new stake in Azenta during the 2nd quarter worth about $33,212,000. Finally, American Capital Management Inc. boosted its stake in shares of Azenta by 26.9% during the 1st quarter. American Capital Management Inc. now owns 1,296,024 shares of the company’s stock worth $27,385,000 after buying an additional 274,588 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.
About Azenta
Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.
Further Reading
- Five stocks we like better than Azenta
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
